Us Congress 2023-2024 Regular Session

Us Congress Senate Bill SB3137

Introduced
10/26/23  

Caption

Support Through Loss Act

Impact

If enacted, SB3137 would establish a federal mandate requiring employers to offer not less than 56 hours of paid leave annually for reasons tied to pregnancy loss, fertility related issues, or other significant health events. Employers would be required to implement this leave without altering existing policies that are more favorable. The bill aims to enhance employee protections and rights while ensuring that such leave cannot be incorporated negatively within employer attendance policies.

Summary

SB3137, known as the Support Through Loss Act, aims to provide individuals in the United States with paid leave to deal with personal health issues following pregnancy loss, unsuccessful fertilization procedures, failed adoptions, or surrogacy arrangements. The bill recognizes the emotional and physical toll that these experiences have on individuals and emphasizes the need for supportive policies to help them cope during these difficult times. Its introduction is a significant step toward acknowledging the various facets of reproductive health and related challenges faced by families.

Contention

Despite the bill's supportive intent, there are potential points of contention regarding its implementation and implications for businesses, particularly small employers. Critics may argue about the financial impacts on businesses required to provide additional leave, raising concerns about the strain on small businesses with limited resources. There could also be debates surrounding the definition and scope of eligible circumstances for leave, as well as potential discriminatory practices that may arise in employer responses to employees utilizing their rights under this law.

Companion Bills

US HB6103

Same As Support Through Loss Act

Similar Bills

US HB6103

Support Through Loss Act

NJ A5383

Requires unrestricted Medicaid coverage for ovulation enhancing drugs and medical services related to administering such drugs for certain beneficiaries experiencing infertility.

NJ S4294

Requires unrestricted Medicaid coverage for ovulation enhancing drugs and medical services related to administering such drugs for certain beneficiaries experiencing infertility.

NJ S693

Requires Medicaid coverage for ovulation enhancing drugs and medical services related to administering such drugs for certain beneficiaries experiencing infertility.

NJ A5369

Requires Medicaid coverage for ovulation enhancing drugs and medical services related to administering such drugs for certain beneficiaries experiencing infertility.

NJ S3733

Requires Medicaid coverage for ovulation enhancing drugs and medical services related to administering such drugs for certain beneficiaries experiencing infertility.

NJ A3503

Requires Medicaid coverage for remote stress tests for pregnant women.

NJ S2812

Requires Medicaid coverage for remote stress tests for pregnant women.